G

Gelteq Ltd
NASDAQ:GELS

Watchlist Manager
Gelteq Ltd
NASDAQ:GELS
Watchlist
Price: 1.03 USD
Market Cap: $11m

Operating Margin

-4 469.7%
Current
Improving
by 612.6%
vs 3-y average of -5 082.3%

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
-4 469.7%
=
Operating Income
AU$-5.1m
/
Revenue
AU$165.7k

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
-4 469.7%
=
Operating Income
$-5.1m
/
Revenue
AU$165.7k

Peer Comparison

Country Company Market Cap Operating
Margin
AU
Gelteq Ltd
NASDAQ:GELS
11m USD
Loading...
US
Eli Lilly and Co
NYSE:LLY
969.6B USD
Loading...
US
Johnson & Johnson
NYSE:JNJ
547.3B USD
Loading...
CH
Roche Holding AG
SIX:ROG
277.1B CHF
Loading...
UK
AstraZeneca PLC
LSE:AZN
209.4B GBP
Loading...
CH
Novartis AG
SIX:NOVN
219B CHF
Loading...
US
Merck & Co Inc
NYSE:MRK
271.3B USD
Loading...
DK
Novo Nordisk A/S
CSE:NOVO B
1.7T DKK
Loading...
IE
Endo International PLC
LSE:0Y5F
218B USD
Loading...
US
Pfizer Inc
NYSE:PFE
148.3B USD
Loading...
FR
Sanofi SA
PAR:SAN
93.8B EUR
Loading...

Market Distribution

Lower than 87% of companies in Australia
Percentile
13th
Based on 3 951 companies
13th percentile
-4 469.7%
Low
-14 949 200% — -526.4%
Typical Range
-526.4% — 6.1%
High
6.1% — 145 596.9%
Distribution Statistics
Australia
Min -14 949 200%
30th Percentile -526.4%
Median -25.2%
70th Percentile 6.1%
Max 145 596.9%

Gelteq Ltd
Glance View

Market Cap
11m USD
Industry
Pharmaceuticals

Gelteq Ltd is a AU-based company operating in Pharmaceuticals industry. The company is headquartered in Melbourne, Victoria. The company went IPO on 2024-10-29. Gelteq Limited is an Australia-based clinical and science-based company. The firm is focused on developing and commercializing white-label gel-based delivery solutions for prescription drugs, nutraceuticals, pet care and other products. The firm offers a complete end-to-end service for the development of new products and the conversion of existing products and formulations into gels. Its product suite consists of multiple products that sit within five core verticals - for pets, sports, pharmaceuticals (pharma), over-the-counter (OTC) and nutraceuticals. The Company’s delivery system provides pharma and nutraceutical enhancements throughout every stage of ingestion in both animals and humans, addressing the complete experience from the point of ingestion to final absorption. The firm also offers a highly versatile portfolio of pre-tested and market-ready proprietary formulations that can be white-labelled.

GELS Intrinsic Value
HIDDEN
Show
What is Operating Margin?
Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.
How is Operating Margin calculated?

Operating Margin is calculated by dividing the Operating Income by the Revenue.

Operating Margin
-4 469.7%
=
Operating Income
AU$-5.1m
/
Revenue
AU$165.7k
What is Gelteq Ltd's current Operating Margin?

The current Operating Margin for Gelteq Ltd is -4 469.7%, which is above its 3-year median of -5 082.3%.

How has Operating Margin changed over time?

Over the last 2 years, Gelteq Ltd’s Operating Margin has increased from -4 770.9% to -4 469.7%. During this period, it reached a low of -5 829.5% on Jun 30, 2023 and a high of -4 646.4% on Jul 30, 2025.

Back to Top